GXL

GXL is a company headquartered in the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

GXL develops AI software to accelerate drug discovery and biomedical research by enabling researchers to search, read, and analyze millions of scientific papers, regulatory documents, and biological databases through a command line interface and agentic platform.